Novel RET Fusion RET-SEPTIN9 Predicts Response to Selective RET Inhibition With Selpercatinib in Malignant Pheochromocytoma.

Angela Mweempwa Huiling Xu Joseph H A VissersRichard W TothillAndrew D Pattison Andrew P FellowesDavid M ThomasGary Richardson Rodney John Hicks Sean M Grimmond Stephen B Fox Stephen J Luen Jayesh Desai Benjamin J Solomon

Published in: JCO precision oncology (2022)

Keyphrases